Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.daikaffil.com | |
Market Cap | 14.21 Cr. | |
Enterprise Value(EV) | 4.41 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.38 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 26.51 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 21.35 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.11 | Calculated using Price: 23.69 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.60 Cr. | 6,000,000 Shares |
FaceValue | 10 | |
Company Profile | ||
Daikaffil Chemicals India, established in 1992, is a chemical manufacturing company .They have come a long way since and established a name in the chemical industry. Other than the production of chemicals, which after processing becomes a part of everyone's day to day life, Daikaffil entered the consumer arena in 1995 by converting into a public limited company. |
1 Day |
|
-1.86% |
1 Week |
|
+0.68% |
1 Month |
|
-6.14% |
3 Month |
|
-4.73% |
6 Month |
|
-12.45% |
1 Year |
|
-17.96% |
2 Year |
|
-11.40% |
5 Year |
|
-62.77% |
10 Year |
|
+121.50% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 14.73 | 14.67 | 18.03 | 17.45 | 14.63 | 5.04 | 6.26 | -2.33 | -15.77 | |
Return on Capital Employed (%) | 21.50 | 19.01 | 25.66 | 26.05 | 19.40 | 7.33 | 9.06 | -2.30 | -16.97 | |
Return on Assets (%) | 6.46 | 6.84 | 10.23 | 9.54 | 7.56 | 2.83 | 3.71 | -1.38 | -9.13 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 10 | 11 | 13 | 24 | 26 | 25 | 26 | 26 | 25 | 23 | |
Non Curr. Liab. | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Curr. Liab. | 14 | 9 | 7 | 5 | 6 | 2 | 3 | 2 | 1 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 25 | 21 | 20 | 31 | 33 | 28 | 30 | 29 | 26 | 24 | |
Non Curr. Assets | 6 | 6 | 6 | 16 | 17 | 15 | 14 | 14 | 14 | 14 | |
Curr. Assets | 19 | 15 | 15 | 15 | 15 | 14 | 16 | 15 | 12 | 11 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 25 | 21 | 20 | 31 | 33 | 28 | 30 | 29 | 26 | 24 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 33 | 34 | 27 | 26 | 23 | 17 | 16 | 11 | 8 | 2 | |
Other Income | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | |
Total Income | 34 | 35 | 28 | 27 | 24 | 17 | 17 | 12 | 9 | 2 | |
Total Expenditure | -30 | -32 | -24 | -22 | -20 | -15 | -14 | -11 | -10 | -4 | |
PBIDT | 3 | 3 | 4 | 5 | 4 | 2 | 3 | 1 | -2 | -1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | -3 | -2 | |
Adjusted EPS | 2 | 3 | 4 | 4 | 4 | 1 | 2 | -1 | -4 | -3 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 1 | 2 | 1 | 5 | 3 | 2 | 3 | 0 | -1 | |
Cash Fr. Inv. | 0 | 0 | -1 | 0 | -1 | -3 | 2 | 0 | 0 | 0 | |
Cash Fr. Finan. | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | |
Net Change | 0 | 1 | 1 | 0 | 3 | -1 | 3 | 3 | 0 | -1 | |
Cash & Cash Eqvt | 0 | 1 | 2 | 1 | 4 | 3 | 6 | 9 | 9 | 9 |
Thu, 09 Feb 2023
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31 2022 Pursuant to Regulation 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are forwarding herewith a copy of Unaudited Financial Results for the Quarter ended 31.12.2022. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held on 09.02.2023 (i.e. today). We also enclose "Limited Review Report" dated 09.02.2023 issued by Statutory Auditors M/S. NGST & Associates Chartered Accountants in respect of Unaudited Financial Results for the Quarter ended 31.12.2022. |
Tue, 31 Jan 2023
Board Meeting Intimation for Unaudited Financial Results For Quarter Ended December 31 2022 DAIKAFFIL CHEMICALS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve This is to inform you pursuant to Regulation 29 (1) (a) of Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations 2015 that a meeting of the Board of Directors of the Company will be held on Thursday the 09th Feb 2023 at Mumbai inter alia:To consider and approve un-audited Financial Results of the Company for the quarter ended December 31 2022.Further pursuant SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time the Trading Window as informed to the exchange vide letter dated 30.12.2022 in respect of trading in equity shares of the Company will remain closed upto 11th Feb 2023. |
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 ln compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 20l8 we are forwarding herewith a copy of the Certificate dated 07th January 2023 received from the Registrar and Share Transfer Agent of the Company for the Quarter ended December 31 2022. |
Tue, 21 Mar 2023 |
|
|
|
|
|